Abstract |
This study was undertaken to examine the effects of two acetylcholinesterase inhibitors ( donepezil and physostigmine) on cognitive deficits in mice after repeated administration of the NMDA receptor antagonist phencyclidine (PCP). In the novel object recognition test, PCP (10 mg/kg/day for 10 days)-induced cognitive deficits were significantly improved by subsequent subchronic (14 days) administration of donepezil (1.0 mg/kg/day), but not donepezil (0.1 mg/kg/day). Furthermore, the effect of donepezil (1.0 mg/kg/day) on PCP-induced cognitive deficits was significantly antagonized by co-administration of the selective sigma-1 receptor antagonist NE-100 (1.0 mg/kg/day), suggesting the role of sigma-1 receptors in the active mechanisms of donepezil. In contrast, PCP-induced cognitive deficits were not improved by subsequent subchronic (14 days) administration of physostigmine (0.25 mg/kg/day). Moreover, repeated administration of PCP significantly caused the reduction of sigma-1 receptors in the hippocampus. The present study suggests that agonistic activity of donepezil at sigma-1 receptors plays a role in the active mechanisms of donepezil on PCP-induced cognitive deficits in mice. Therefore, it is likely that donepezil would be potential therapeutic drugs for the treatment of the cognitive deficits in schizophrenia.
|
Authors | Shinsui Kunitachi, Yuko Fujita, Tamaki Ishima, Mami Kohno, Mao Horio, Yuko Tanibuchi, Yukihiko Shirayama, Masaomi Iyo, Kenji Hashimoto |
Journal | Brain research
(Brain Res)
Vol. 1279
Pg. 189-96
(Jul 07 2009)
ISSN: 1872-6240 [Electronic] Netherlands |
PMID | 19433073
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anisoles
- Cholinesterase Inhibitors
- Indans
- Piperidines
- Propylamines
- Receptors, sigma
- Tritium
- N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride
- Donepezil
- Physostigmine
- Phencyclidine
|
Topics |
- Analysis of Variance
- Animals
- Anisoles
(pharmacology)
- Brain
(drug effects, metabolism)
- Cell Membrane
(metabolism)
- Cholinesterase Inhibitors
(pharmacology)
- Cognition Disorders
(chemically induced, drug therapy)
- Donepezil
- Hippocampus
(drug effects, metabolism)
- Immunohistochemistry
- Indans
(pharmacology)
- Male
- Mice
- Mice, Inbred ICR
- Phencyclidine
- Physostigmine
(pharmacology)
- Piperidines
(pharmacology)
- Propylamines
(pharmacology)
- Receptors, sigma
(antagonists & inhibitors, metabolism)
- Recognition, Psychology
(drug effects)
- Tritium
- Sigma-1 Receptor
|